Agree. The raise at lower prices is inevitable. Partnership chances have largely dimmed ever since they recruited and beefed up commercial roles. Second, if none happened even with all the roadshows and ‘spectacular’ data, it casts more doubts at least on any that favors RVNC.
I think every Wall Street Uncle, Aunt & their cousins are waiting on FDA label for 6 mos. if they don’t get that label, no different than Botox from commercial prospects POV. And 500 lb gorilla AGN will be merciless
In my books, Dan has screwed the shareholders purely on incompetency to sell the story.
Market Data 
Markets 
AI
